Stromal Interferon-γ Signaling and Cross-Presentation Are Required to Eliminate Antigen-Loss Variants of B Cell Lymphomas in Mice

• Armin Gerbitz ,

  Contributed equally to this work with: Armin Gerbitz, Madhusudhanan Sukumar

  * E-mail: armin.gerbitz@uk-erlangen.de

  Affiliations Department of Immunology, Charité Berlin, Berlin, Germany, Department of Hematology and Oncology, University of Erlangen, Erlangen, Germany

  ⨯
• Madhusudhanan Sukumar ,

  Contributed equally to this work with: Armin Gerbitz, Madhusudhanan Sukumar

  Current address: Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center Munich, Munich, Germany

  ⨯
• Florian Helm,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Andrea Wilke,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Christian Friese,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Cornelia Fahrenwaldt,

  Affiliations Department of Immunology, Charité Berlin, Berlin, Germany, Department of Hematology and Oncology, University of Erlangen, Erlangen, Germany

  ⨯
• Frank M. Lehmann,

  Affiliation Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center Munich, Munich, Germany

  ⨯
• Christoph Loddenkemper,

  Affiliation Department of Pathology, Charité Berlin, Berlin, Germany

  ⨯
• Thomas Kammertoens,

  Affiliation Department of Immunology, Charité Berlin, Berlin, Germany

  ⨯
• Josef Mautner,

  Affiliations Department of Pediatrics, Technical University (TU) Munich, Munich, Germany, Clinical Cooperation Group Pediatric Tumor Immunology, TU Munich and Helmholtz Center Munich, Munich, Germany

  ⨯
• Clemens A. Schmitt,

  Affiliation Department of Hematology and Oncology, Charite Berlin, Berlin, Germany

  ⨯
• Thomas Blankenstein,

  Affiliations Department of Immunology, Charité Berlin, Berlin, Germany, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany

  ⨯
• Georg W. Bornkamm

  Affiliation Institute of Clinical Molecular Biology and Tumor Genetics, Helmholtz Center Munich, Munich, Germany

  ⨯